WELCOME TO
BSG LIVE’25

Ipsen U.K. and Ireland is a core part of Ipsen’s global biopharmaceutical business and is driven by the belief that patients don’t have time to wait. We have a biotech mindset coupled with pharmaceutical capabilities and have invested in a robust business presence that spans the early stages of research and development (R&D) through to in-house manufacturing in Wrexham, Wales and Dublin, Ireland, so we can effectively deliver on our promise to U.K. and Irish patients. As part of this investment, we employ over 1,000 people across three sites, representing about 17% of our global workforce, of which over 300 are based in London, home to one of our three Global Hubs alongside Paris, France and Cambridge in the U.S.

At Ipsen, we focus on ensuring innovative solutions reach the people that need it most in oncology, rare disease and neuroscience. We push ourselves to address the most complex and difficult issues facing people’s health to deliver better outcomes. This purpose driven approach ensures we deliver real impact, in a sustainable way, for patients and society. Our licensed medicines and R&D are all focused on improving quality of life and relieving suffering, hoping to bring real value to the healthcare community along every step of the treatment pathway.

ALLSC-GB-000601 | August 2024